mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.2 |